Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GCLC | P48506 | 1/20 | 0.59 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.53 |
| ▸ | SLC1A2 | P43004 | 4/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 4/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 3/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 5/20 | 0.49 |
| ▸ | GRIK2 | Q13002 | 4/20 | 0.49 |
| ▸ | DDAH1 | O94760 | 3/20 | 0.46 |
| ▸ | GSR | P00390 | 2/20 | 0.44 |
| ▸ | NOS1 | P29475 | 3/20 | 0.44 |
| ▸ | NOD1 | Q9Y239 | 2/20 | 0.42 |
| ▸ | GRM8 | O00222 | 1/20 | 0.42 |
| ▸ | GRM6 | O15303 | 1/20 | 0.42 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.42 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | GRM5 | P41594 | 1/20 | 0.42 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.42 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.42 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11738674 | 1.00 | GCLC (0.59) | GCLCPMP22SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL11739545 | 0.88 | GCLC (0.62) | GCLCPMP22SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL31661813 | 0.85 | GCLC (0.62) | GCLCPMP22SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL11735940 | 0.84 | GCLC (0.67) | GCLCPMP22SLC1A2SLC1A1SLC1A3 | |
| SCHEMBL1157698 | 0.84 | GCLC (0.67) | GCLCPMP22SLC1A2SLC1A1SLC1A3 | |
| Buthionine Sulfoxime SCHEMBL121171 | 0.81 | PMP22 (0.59) | GCLCPMP22SLC1A2SLC1A1SLC1A3 | |
| Buthionine Sulfoxime SCHEMBL115963 | 0.81 | PMP22 (0.59) | GCLCPMP22SLC1A2SLC1A1SLC1A3 | |
| Buthionine Sulfoxime SCHEMBL62034 | 0.81 | PMP22 (0.59) | GCLCPMP22SLC1A2SLC1A1SLC1A3 | |
| Buthionine Sulfoxime SCHEMBL9300391 | 0.81 | PMP22 (0.59) | GCLCPMP22SLC1A2SLC1A1SLC1A3 | |
| Buthionine Sulfoxime SCHEMBL4449935 | 0.81 | PMP22 (0.59) | GCLCPMP22SLC1A2SLC1A1SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 414 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4376995-A1 | BIOBASED CORE-SHELL MICROCAPSULES | Symrise AG (DE) | 2024-06-05 | — | — | EP | disclosed |
| EP-3432858-B1 | NON-THERAPEUTIC USE OF CARNOSINES | SYMRISE AG (DE) | 2023-12-27 | — | — | EP | disclosed |
| EP-4252737-A1 | SUNSCREEN COMPOSITION FOR PROTECTING THE SKIN FROM VISIBLE LIGHT | STADA ARZNEIMITTEL AG (DE) | 2023-10-04 | — | — | EP | disclosed |
| US-11773060-B2 | Method for synthesis of 9-cis-beta-carotene and formulations thereof | RAMOT AT TEL-AVIV UNIVERSITY LTD. (IL) | 2023-10-03 | — | — | US | disclosed |
| EP-3536383-B1 | CLEANING AND CARE PREPARATIONS COMPRISING A POLYOXYALKYLENE CARBOXYLATE | PERFECT IDEAS GMBH (CH) | 2023-09-27 | — | — | EP | disclosed |
| EP-3536769-B1 | WASHING AND CLEANING COMPOSITION COMPRISING A POLYOXYALKYLENE CARBOXYLATE | PERFECT IDEAS GMBH (CH) | 2023-08-16 | — | — | EP | disclosed |
| EP-2034949-B2 | METHOD FOR INCREASING THE SUN PROTECTION FACTOR OF A COSMETIC AND/OR DERMATOLOGICAL PREPARATION | BASF SE (DE) | 2023-06-28 | — | — | EP | disclosed |
| CN-116348086-A | Surfactant-containing formulations of ceramide | 西姆莱斯股份公司 | 2023-06-27 | — | — | CN | disclosed |
| CN-115942870-A | Composition with virucidal and/or antiviral activity | 西姆莱斯股份公司 | 2023-04-07 | — | — | CN | disclosed |
| CN-115701970-A | Method for producing a personalized cosmetic preparation | 巴斯夫欧洲公司 | 2023-02-14 | — | — | CN | disclosed |
| US-5961959-A | Cosmetic and dermatological light protection formulations having a content of triazine derivatives and monoesters and diesters of branched alkanecarboxylic acids and diglycerol or triglycerol | BEIERSDORF AG (DE) | 1999-10-05 | — | — | US | disclosed |
| US-5952373-A | APPLYING TO THE SKIN AN EFFECTIVE AMOUNT OF ONE OR MORE FLAVONOIDS | BEIERSDORF AG (DE) | 1999-09-14 | — | — | US | disclosed |
| US-5876737-A | SKIN DISORDERS | BEIERSDORF AG (DE) | 1999-03-02 | — | — | US | disclosed |
| US-5876702-A | Cosmetic and dermatological light protection formulations in the form of O/W macroemulsions, O/W microemulsions or O/W/O emulsions | BEIERSDORF AG (DE) | 1999-03-02 | — | — | US | disclosed |
| US-5851542-A | Cosmetic and dermatological light protection formulations having a content of triazine derivatives and glycerol mono- or dicarboxylic acid monoesters | BEIERSDORF AG (DE) | 1998-12-22 | — | — | US | disclosed |
| US-5833951-A | OILS, FATS AND/OR WAXES, THICKENERS AND ADDITIVES | BEIERSDORF AG (DE) | 1998-11-10 | — | — | US | disclosed |
| US-5804167-A | OILY PHASE OF NON-POLAR FATS OR WAXES; ONE OR MORE SALTS OF DI- OR TRIVALENT METAL CATIONS AND ONE OR MORE ALKYLCARBOXYLIC ACIDS HAVING 10 TO 24 CARBON ATOMS | BEIERSDORF AG (DE) | 1998-09-08 | — | — | US | disclosed |
| US-5783176-A | CONTAINING ESTER FROM HYDROXYCARBOXYLIC ACID AND SATURATEDALCOHOL; CARING OF LIPS | BEIERSDORF AG (DE) | 1998-07-21 | — | — | US | disclosed |
| US-5759584-A | Method for treating skin afflicted with blemishes or acne with a composition comprising distilled wool wax acids and at least one monoglycerol monocarboxylic acid monoester | BEIERSDORF AG (DE) | 1998-06-02 | — | — | US | disclosed |
| US-5750124-A | W/O/W emulsions | BEIERSDORF AG (DE) | 1998-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11773060-B2 | Method for synthesis of 9-cis-beta-carotene and formulations thereof | BHMT2, CBS, TTPA | GCLC 53/4885PMP22 4257/4885SLC1A2 4296/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.